体外受精(IVF)の世界市場分析:手順別(細胞内精子注入(ICSI)、凍結胚交換(FER)、着床前遺伝診断(PGD))、サイクルタイプ別(フレッシュ・ドナー、フローズン・ドナー、フレッシュ・ノン・ドナー、フローズン・ノン・ドナー)、機器別(IVDディスポーザブルデバイス、培養培地、資本設備)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)), By Types of Cycles (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), By Instruments (IVD Disposable Devices, Culture Media, Capital Equipment), And Segment Forecasts to 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. In-Vitro Fertilization (IVF) Market – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. In-Vitro Fertilization (IVF)Industry Outlook
3.1. In-Vitro Fertilization (IVF) Market Segmentation
3.2. In-Vitro Fertilization (IVF) Market Size and Growth Prospects
3.3. In-Vitro Fertilization (IVF) Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry analysis – Porter’s
3.6. In-Vitro Fertilization (IVF) Market PESTEL Analysis, 2014
3.7. Competitive landscape
Chapter 4. In-Vitro Fertilization (IVF)Procedures Outlook
4.1. In-Vitro Fertilization (IVF)Market Share by procedures, 2014 & 2022
4.2. Intracytoplasmic Sperm Injection(ICSI) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.3. Frozen Embryo Replacement (FER) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.4. Pre-implantation Genetic Diagnosis (PGD) Market Estimates and Forecasts, 2012 – 2022 (USD Million)
4.5. Others Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 5. In-Vitro Fertilization (IVF) Type of Cycles Outlook
5.1. In-Vitro Fertilization (IVF) Market Share by type of cycles, 2014 & 2022
5.2. Fresh Donor Market Estimates and Forecasts, 2012 – 2022 (USD Million)
5.3. Fresh Non-donor Market Estimates And Forecasts, 2012 – 2022 (USD Million)
5.4. Frozen Donor Market Estimates and Forecasts, 2012 – 2022 (USD Million)
5.5. Frozen Non-donor Market Estimates And Forecasts, 2012 – 2022 (USD Million)
Chapter 6. In-Vitro Fertilization (IVF) Instruments Outlook
6.1. In-Vitro Fertilization (IVF) Market Share by instruments, 2014 & 2022
6.2. Culture media Market Estimates and Forecasts, 2012 – 2022 (USD Million)
6.3. Capital equipment Market Estimates and Forecasts, 2012 – 2022 (USD Million)
6.4. IVF disposable devices Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 7. In-Vitro Fertilization (IVF)Regional Outlook
7.1. North America
7.1.1. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.1.1.1. U.S. Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.1.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.2. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.1.2.1. U.S Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.2.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.3. North America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.1.3.1. U.S. Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.1.3.2. Canada Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2. Europe
7.2.1. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.2.1.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.1.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.1.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.2.2.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.2.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.2.3.1. UK Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3.2. France Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.2.3.3. Germany Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3. Asia Pacific
7.3.1. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.3.1.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.1.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.1.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.3.2.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.2.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.3.3.1. India Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3.2. China Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.3.3.3. Japan Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.4. Latin America
7.4.1. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.4.1.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.1.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.2. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.4.2.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.2.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.3. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.4.3.1. Mexico market estimates and forecasts, 2012 – 2022 (USD Million)
7.4.3.2. Brazil market estimates and forecasts, 2012 – 2022 (USD Million)
7.5. MEA
7.5.1. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 – 2022 (USD Million)
7.5.1.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.5.2. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 – 2022 (USD Million)
7.5.2.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
7.5.3. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 – 2022 (USD Million)
7.5.3.1. South Africa Market Estimates and Forecasts, 2012 – 2022 (USD Million)
Chapter 8. Competitive Landscape
9.1 OvaScience
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product Benchmarking
9.1.4 Strategic Initiatives
9.2 Vitrolife AB
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product Benchmarking
9.2.4 Strategic initiatives
9.3 EMD Serono, Inc.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Products Benchmarking
9.3.4 Strategic initiatives
9.4 Irvine Scientific
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Product Benchmarking
9.4.4 Strategic initiatives
9.5 CooperSurgical, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Products Benchmarking
9.5.4 Strategic initiatives
9.6 Cook Medical, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product Benchmarking
9.6.4 Strategic initiatives
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Products Benchmarking
9.7.4 Strategic initiatives
9.8 Genea Biomedx
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product Benchmarking
9.8.4 Strategic Initiatives
9.9 Progyny,Inc.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Benchmarking
9.9.4 Strategic Initiatives
9.10 Boston IVF
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:体外受精(IVF)の世界市場分析:手順別(細胞内精子注入(ICSI)、凍結胚交換(FER)、着床前遺伝診断(PGD))、サイクルタイプ別(フレッシュ・ドナー、フローズン・ドナー、フレッシュ・ノン・ドナー、フローズン・ノン・ドナー)、機器別(IVDディスポーザブルデバイス、培養培地、資本設備)、セグメント予測
■ 英文:In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)), By Types of Cycles (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), By Instruments (IVD Disposable Devices, Culture Media, Capital Equipment), And Segment Forecasts to 2022
■ 発行日:2016年5月3日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707455
■ 調査対象地域:グローバル
  • Sedation:グローバル臨床試験レビューH1, 2013
    Sedation Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Sedation Global Clinical Trials Review, H1, 2013" provides data on the Sedation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sedation. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • 世界のレーザダイオード市場2015
    Global Laser Diode Industry Report 2015 is a professional and in-depth study on the current state of the Laser Diode industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Laser Diode market analysis is provided for the international markets including development trends, competitive landscape analysis, a …
  • グルホシネートの世界市場:作物種類別(シリアル&穀物、油料種子&豆類、果物&野菜、その他)、製剤種類別(水性懸濁液、液体、懸濁液濃縮物、可溶性(液体)濃縮物、その他)
    The global glufosinate market was valued at $544.8 million in 2018, and is projected to reach $2,097.7 million by 2026, growing at a CAGR of 19.0% from 2019 to 2026. Glufosinate is a naturally occurring herbicide isolated from two species of Streptomyces fungi. It is widely used as a substitute of glyphosate and paraquat and is used to control a wide range of weeds such as morning glories, hemp se …
  • サウジアラビアの食品小売市場2016-2020
    About the Food Retail Market in Saudi Arabia Saudi Arabia is a desert country and is known as the birthplace of Islam. It is home to the religion’s two most sacred mosques, Masjid al-Haram in Mecca and Masjid an-Nabawi in Medina, the burial site of prophet Muhammad. It is the world's largest producer and exporter of petroleum products. It has the world's second-largest oil reserves and sixth-large …
  • 世界におけるマイクロサーバーIC市場分析及び予測(2013 – 2018)
    Micro servers are small server appliances that are used in low power processor chips and places where space is a major constraint. These are designed for the ease of installation and maintenance. A micro server is a popular choice among the small- to medium-sized business units that require a server but do not necessarily need a full-scale rack or tower server. Micro servers find their major appli …
  • 世界の軍隊・軍事IT、データ、コンピューティング市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the Military IT, Data and Computing market. It provides an overview of key Military IT, Data and Computing companies catering to the Military IT, Data and Computing sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global military IT, data and computing industry is …
  • BaaS(バイオメトリクスサービス)の世界市場2016-2020
    About Biometrics as a Service In 1999, biometrics was introduced as an application to render authentication after identifying and verifying biological and physiological traits such as voice, palm geometry, DNA, gait, fingerprints, facial features, iris, signature, and vein geometry. This technology is reliable, as it cannot be lost or forgotten by an individual. Verification is a one-to-one matchi …
  • 世界の銅産業動向
    The global copper industry expanded by over 40% in 2011 and accounted for $90 billion in revenues. The copper industry was greatly affected by a global drop in commodity prices in 2009, which caused a sharp decline in many markets. However, the decline was promptly reversed by increased consumption especially by fast developing countries like China. The mining of copper is generally confined to a …
  • 世界のマラリア検査市場
    The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commerci …
  • ビックデータ分野のリーディング企業分析:HP
    Big Data represents a collection of data sets so large and complex that it becomes difficult to process using on-hand database management tool. It is also unstructured, meaning that it is not tabulated, correlated, etc. (e.g. it does not have a pre-defined data model or is not organized in a pre-defined manner). Big Data technologies enable organizations to handle huge datasets and generate inform …
  • ソース及びドレッシングの世界市場
    About Sauces and Dressings Sauces are usually used as a dip, a glaze, a filling, and an accompaniment with food. The most common types of sauces used by consumers worldwide are tomato sauce (ketchup), soy sauce, mustard sauce, chili sauce, béchamel sauce, and hollandaise sauce. Whereas dressings are used for garnishing and giving taste to food products, especially salads, burgers, sandwiches, and …
  • 結晶セルロース(MCC)の世界市場動向及び予測
    Microcrystalline cellulose (MCC) is used as binder, thickening agent, suspension agent, and bulking agent in a variety of application such as food & beverages, pharmaceutical, cosmetics & personal care, and others. This report on the global MCC market covers all major regions such as Asia-Pacific, Europe, North America, and Rest of the World. The report analyzes the market trends and provides fore …
  • Xarelto(ACS/急性冠症候群):医薬品市場予測及び分析(~2023)
    Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are …
  • 止血(Hemostasis):世界の治験レビュー(2015年上半期版)
    Hemostasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2015" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across t …
  • 代用骨移植片:企業と競争環境
    MediPoint: Bone Grafts and Substitutes - Current and Future Players Summary Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in devel …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。